HIV Treatment Strategies
The Latest
This Week in HIV Research: Life in the Integrase Era
Aug. 6, 2020: Recent trends in drug interaction rates; integrase inhibitors and cardiac event risk; a deep dive into HIV drug resistance in Florida; frailty symptoms and neurocognitive disorders amidst high CD4 counts.
Researcher Behind "Brazil Patient," the Latest HIV Remission Case, Explains How It Happened
The international news story that broke at AIDS 2020, explained by the lead researcher.
This Champion of Community’s Role in Clinical Trials Reflects on 40 Years of Fighting Medical Mistrust And Research Neglect
Wakefield retires from the HIV Vaccine Trials Network after 20 years of service.
This Week in HIV Research: Solving the Riddle of Poor PrEP Uptake
July 30, 2020: HIV prevention shortfalls among adolescents of color; PrEP use among trans people; PrEP information gaps among women of color; the case for vacation-based (a.k.a. episodic) PrEP.
What Are the New HIV Treatment and Prevention Drugs Under Development in 2020?
Richard Jefferys of Treatment Action Group discusses the pipeline for new modalities being explored for treatment, PrEP, vaccine, and cure.
This Week in HIV Research: Links in a Chain
July 16, 2020: Starting HIV treatment during hospitalization for people who use drugs; type of substance use affects viral suppression odds; benefits of a cross-disciplinary medical support team; does STI recency dictate PrEP necessity for women?
HIV Clinical Research Highlights From AIDS 2020, the 23rd International AIDS Conference
COVID-19 or no, there was still plenty to learn at this year's virtual conference, including for U.S. clinicians seeking to improve the care and treatment they provide to their patients living with HIV.
This Week in HIV Research: Do As We Say, Not As We Do
July 9, 2020: Abysmal HIV testing rates in U.S. ambulatory care settings; STI testing frequency in PrEP users; trends in U.S. PrEP uptake; integrating opioid therapy with HCV care in people who inject drugs.
As Two-Drug HIV Treatment Rises, Long-Term Inflammation Becomes a Potential Concern
These studies presented at AIDS 2020 explore the benefits and challenges.
This Week in HIV Research: So Many Relative Risks
July 1, 2020: Quantifying bone fracture risks; real-world lipid effects of switching to TAF; pulmonary function impairment in MSM; immunomodulatory drugs and viral load blips.